How Much Does Tirzepatide Cost in 2026?

Eli Lilly manufactures and markets tirzepatide under two brand names:

• Mounjaro (for type 2 diabetes) — $800 to $1,200 per month without insurance
• Zepbound (for weight management) — $1,000 to $1,500 per month without insurance

Insurance and coverage considerations:

• Commercial insurance — Coverage for Mounjaro (diabetes indication) is more common than Zepbound (weight loss). Copays range from $25-300+ depending on formulary tier.
• Eli Lilly savings card — May reduce costs to $25/month for eligible commercially insured patients with coverage.
• Medicare/Medicaid — Coverage is expanding but varies by plan. Step therapy requirements are common.
• Cash pay — Eli Lilly has introduced direct-to-consumer options for Zepbound at reduced cash prices in some markets.

Compounded tirzepatide is available at significantly lower prices through licensed pharmacies:

• Telehealth-bundled programs — $250 to $450 per month, including provider consultation and medication
• Compounding pharmacy with Rx — $200 to $400 per month with a valid prescription from your provider
• Subscription models — Some programs offer $225-375/month with auto-refill commitments

Tirzepatide’s compounded pricing tends to run slightly higher than compounded semaglutide due to the more complex peptide structure and manufacturing process. When comparing providers, request a complete cost breakdown including all fees.

For laboratory research purposes, tirzepatide is available from peptide research vendors:

• 5mg vial — $40 to $60 from established vendors
• 10mg vial — $60 to $80 from established vendors

Research-grade tirzepatide pricing reflects the complexity of synthesizing this 39-amino acid dual-agonist peptide. As with all research peptides, quality and purity vary between vendors. Prioritize suppliers with third-party HPLC testing and published COAs.

Research peptides are sold strictly for laboratory research and are not intended for human use. Comply with all applicable regulations.

Several approaches can make tirzepatide more affordable:

• Insurance prior authorization — If initially denied, work with your provider to submit a prior authorization with supporting clinical documentation.
• Manufacturer programs — Eli Lilly’s savings cards and patient assistance programs can dramatically reduce costs for eligible patients.
• Compounding pharmacy comparison — Prices vary 30-50% between compounding providers. Shop around and compare total costs.
• Dose-sharing awareness — Some patients work with providers on dose optimization strategies that may affect monthly costs.
• FSA/HSA funds — Prescription tirzepatide (brand or compounded) may be eligible for flexible spending or health savings account reimbursement.

Consult a healthcare provider for personalized medical and financial guidance regarding tirzepatide. This article is informational only.